Clinical Trial Update: A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany

View source ↗

Summary

Pfizer-sponsored retrospective observational study in Germany on the epidemiology and outcomes of transthyretin amyloid cardiomyopathy (ATTR-CM); the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: Pfizer | Conditions: ATTR-CM (Transthyretin Amyloid Cardiomyopathy) | Status: NOT_YET_RECRUITING